All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

18

Reset

18 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Maridebart cafraglutideAMG 133Phase 314 trials

    Amgen · Obesity, Overweight, Obstructive Sleep Apnea

  • AmrubicinJapan onlyPhase 34 trials

    Gilead Sciences · Small Cell Lung Cancer, Extensive Stage Small Cell Lung Cancer (ES-SCLC), Small Cell Lung Cancer (SCLC)

  • DazodalibepVIB 4920, MEDI 4920Phase 33 trials

    Amgen · Sjögren's Syndrome (SS), Sjögren's Syndrome, Sjogren's Syndrome

  • OlpasiranAMG 890Phase 33 trials

    Amgen · Cardiovascular Disease, Atherosclerotic Cardiovascular Disease

  • RocatinlimabAMG 451Phase 33 trials

    Amgen · Atopic Dermatitis

  • ABP 206Phase 32 trials

    Amgen · Melanoma

  • ABP 234Phase 32 trials

    Amgen · Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC), Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

  • BisphosphonatePhase 32 trials

    Ultragenyx Pharmaceutical Inc · Osteogenesis Imperfecta

  • XaluritamigAMG 509Phase 32 trials

    Amgen · Metastatic Castration-resistant Prostate Cancer

  • ABP 692Phase 31 trial

    Amgen · Relapsing-remitting Multiple Sclerosis (RRMS)

  • ABP 938Phase 31 trial

    Amgen · Neovascular Age-related Macular Degeneration, nAMD

  • BemarituzumabPhase 31 trial

    Amgen · Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

  • Amgen · Melanoma

  • Amgen · Melanoma

  • AnvumetostatAMG 193Phase 23 trials

    Amgen · Advanced MTAP-null Solid Tumors, MTAP-deleted NSCLC, MTAP-null Non-Small-Cell Lung Cancer

  • AMG 732Phase 22 trials

    Amgen · Thyroid Eye Disease

  • DaxdilimabHZN-7734Phase 21 trial

    Amgen · Idiopathic Inflammatory Myositis

  • IDE397Phase 21 trial

    Amgen · MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.